Food Law News - EU - 2006

EFSA Statement, 17 November 2006

GM FOOD - Opinion of the GMO Panel related to the safeguard clause invoked by Greece according to Article 23 of Directive 2001/18/EC and to Article 18 of Directive 2002/53/EC

Adopted on 7 November 2006. (Question No EFSA-Q-2006-048)

Following a review of scientific information provided by EU Member State Greece and a meeting with Greek experts in July 2006, EFSA has found no new evidence that would change the risk assessment of MON810 maize which currently has marketing consent in the EU. The EFSA GMO Panel also found that there was insufficient scientific evidence that the environment or ecology of Greece was different from other regions in the EU to merit separate risk assessments in addition to those already conducted in other EU regions.

In conclusion:

SCP, 1998. Opinion of the Scientific Committee on Plants regarding the genetically modified, insect resistant maize lines notified by the Monsanto Company (Notification C/F/95/12/02).

EFSA MON810 Assessments to date


On 29 March 2006, Greece invoked Article 23 of Directive 2001/18/EC and Article 18 of Directive 2002/53/EC (safeguard clause) to provisionally prohibit the cultivation of the authorised genetically modified maize MON810 on its territory. The European Commission received from Greece a written submission, composed of a scientific report, listing detailed reasons for supporting measures taken by Greece , and of 71 publications and statements.

As a consequence, the European Commission requested in a letter dated 4 May, 2006 a scientific opinion as to whether the scientific report and publications submitted by the Greek authorities show that there is an imminent danger for human health and the environment due to the cultivation of the maize varieties with the genetic modification MON810 expressing CRY1Ab protein.

Following investigation of the evidences presented in the Greek submission, EFSA's Scientific Panel on Genetically Modified Organisms (GMO Panel) concludes that, in terms of risk to human health and the environment, no new scientific evidence was presented that would invalidate the risk assessment of genetically modified maize MON810 established under Directive 90/220/EEC (repealed by Directive 2001/18/EC from 17 October 2002). The GMO Panel concluded that MON810 maize is unlikely to have adverse effects on human and animal health or on the environment due to the cultivation of the maize varieties with the genetic modification MON810 in Greece .

To go to main Foodlaw-Reading Index page, click here.